Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation Task Force on E, Prevention, Hational Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study of O (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645
Article CAS PubMed Google Scholar
Yki-Järvinen H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2:901–910
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ, American Gastroenterological A, American Association for the Study of Liver D, American College of G (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592–1609
Rector RS, Thyfault JP, Wei Y, Ibdah JA (2008) Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14:185–192
Article CAS PubMed PubMed Central Google Scholar
Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77:1335–1347
Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419
Article CAS PubMed Google Scholar
Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, Byrne CD, Targher G (2021) Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol 6:903–913
Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G (2021) Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut 70:962–969
Article CAS PubMed Google Scholar
Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, Tilg H, Byrne CD, Targher G (2022) Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut 71:156–162
Zhang Y, Zhang T, Zhang C, Tang F, Zhong N, Li H, Song X, Lin H, Liu Y, Xue F (2015) Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. BMJ Open 5:e008204
Article PubMed PubMed Central Google Scholar
Wainwright P, Byrne CD (2016) Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome. Int J Mol Sci 17:367
Article PubMed PubMed Central Google Scholar
Im HJ, Ahn YC, Wang JH, Lee MM, Son CG (2021) Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clin Res Hepatol Gastroenterol 45:101526
Contreras D, González-Rocha A, Clark P, Barquera S, Denova-Gutiérrez E (2023) Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: systematic review and meta-analysis. Ann Hepatol 28:100873
Article CAS PubMed Google Scholar
Mori K, Tanaka M, Higashiura Y, Hanawa N, Ohnishi H, Furuhashi M (2022) High fatty liver index is an independent predictor of ischemic heart disease during a 10-year period in a Japanese population. Hepatol Res 52:687–698
Article CAS PubMed Google Scholar
Pastori D, Sciacqua A, Marcucci R, Del Ben M, Baratta F, Violi F, Pignatelli P, group A-As (2021) Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study. Intern Emerg Med 16:2063–2068
Article PubMed PubMed Central Google Scholar
Roh JH, Park JH, Lee H, Yoon YH, Kim M, Kim YG, Park GM, Lee JH, Seong IW (2020) Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a Nationwide Population-Based Study in Korea. BMC Cardiovasc Disord 20:204
Article PubMed PubMed Central Google Scholar
Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, Park JY, Lee KU, Ko KS, Lee BW (2014) Background and data configuration process of a nationwide population-based study using the Korean National Health Insurance System. Diabetes Metab J 38:395–403
Article PubMed PubMed Central Google Scholar
Kim JH, Moon JS, Byun SJ, Lee JH, Kang DR, Sung KC, Kim JY, Huh JH (2020) Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study. Cardiovasc Diabetol 19:51
Article CAS PubMed PubMed Central Google Scholar
Park J, Kim G, Kim H, Lee J, Lee YB, Jin SM, Hur KY, Kim JH (2021) The association of hepatic steatosis and fibrosis with heart failure and mortality. Cardiovasc Diabetol 20:197
Article CAS PubMed PubMed Central Google Scholar
Lee YB, Han K, Kim B, Choi MS, Park J, Kim M, Jin SM, Hur KY, Kim G, Kim JH (2021) Risk of early mortality and cardiovascular disease according to the presence of recently diagnosed diabetes and requirement for insulin treatment: A Nationwide Study. J Diabetes Investig 12:1855–1863
Article PubMed PubMed Central Google Scholar
Lee HY, Yang PS, Kim TH, Uhm JS, Pak HN, Lee MH, Joung B (2017) Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study. Sci Rep 7:12716
Article PubMed PubMed Central Google Scholar
Wild SH, Walker JJ, Morling JR, McAllister DA, Colhoun HM, Farran B, McGurnaghan S, McCrimmon R, Read SH, Sattar N, Byrne CD, Epid SDRN (2018) Cardiovascular Disease, Cancer, and mortality among people with Type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care 41:341–347
Younossi ZM, Stepanova M, Rafiq N, Makhlouf H, Younoszai Z, Agrawal R, Goodman Z (2011) Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 53:1874–1882
Kim MK, Han K, Kim HS, Park YM, Kwon HS, Yoon KH, Lee SH (2017) Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study. Eur Heart J 38:3560–3566
Article CAS PubMed PubMed Central Google Scholar
Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75:72–80
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33
Article PubMed PubMed Central Google Scholar
Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, Ding L, Lin L, Xu Y, Chen Y, Lu J, Wang W, Bi Y, Ning G (2015) Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore) 94:e1682
Article CAS PubMed Google Scholar
Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA (2008) Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57:1441–1447
Article CAS PubMed Google Scholar
Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A (2013) In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 62:352–360
Comments (0)